C

CASI Pharmaceuticals
D

CASI

2.37000
USD
-0.04
(-1.66%)
مغلق
حجم التداول
43
الربح لكل سهم
-2
العائد الربحي
-
P/E
-1
حجم السوق
36,717,417
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
الأخبار
المقالات

العنوان: CASI Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.